Cystenyl-leukotriene receptor antagonist (LRA) inhibits respiratory burst of human neutrophils

T. V. Zaharov, S. S. Kamenov, S. S. Cekic, B. A. Kamenov (Pirot, Nis, Yugoslavia)

Source: Annual Congress 2003 - Assessment of acute and severe asthma in children
Session: Assessment of acute and severe asthma in children
Session type: Thematic Poster Session
Number: 2008
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. V. Zaharov, S. S. Kamenov, S. S. Cekic, B. A. Kamenov (Pirot, Nis, Yugoslavia). Cystenyl-leukotriene receptor antagonist (LRA) inhibits respiratory burst of human neutrophils. Eur Respir J 2003; 22: Suppl. 45, 2008

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nicotinic alpha-7 receptor stimulation (a7nAChR) inhibited NF-kB/STAT3/SOCS3 pathways in a murine model of asthma.
Source: International Congress 2017 – Novel mechanisms and treatments for asthma
Year: 2017



A novel receptor antagonist, c-027, inhibits airway contraction in human and murine models of allergen, independent of inflammatory mediator release
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009

Serotonin (5-hydroxytryptamine) modulates cytokine and chemokine production in lipopolysaccharide-primed human monocytes via stimulation of different 5-HT receptor subtypes
Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma
Year: 2005


CS-003, a novel triple neurokinin receptor antagonist, inhibits symptoms of respiratory diseases models in guinea pigs
Source: Eur Respir J 2006; 28: Suppl. 50, 664s
Year: 2006

Enhanced platelet activating factor receptor (PAFR) expression in smoker airways
Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Year: 2011


Mas receptor antagonist inhibits the pro-resolutive effects of Angiotensin-(1-7) in an experimental model of asthma.
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019

The pro-apoptotic effect of cysteinyl leukotriene receptor (CysLT-R) antagonist montelukast is mediated by CysLT-Rs expression on antigen-stimulated T cells
Source: Eur Respir J 2003; 22: Suppl. 45, 100s
Year: 2003

Inhibition of LPS-induced neutrophil recruitment in the lungs correlates with modulation of neutrophil CD11b expression using the selective CXCR2 receptor antagonist SB-656933
Source: Eur Respir J 2004; 24: Suppl. 48, 218s
Year: 2004

Ethanol (EtOH) causes bronchoconstriction and plasma protein extravasation (PPE) in rodent airways via vanilloid receptor 1 (VR1) activation
Source: Eur Respir J 2002; 20: Suppl. 38, 485s
Year: 2002

The selective CXCR2 receptor antagonist SB-656933 inhibits CXCL1-induced neutrophil CD11b expression in human whole blood
Source: Eur Respir J 2004; 24: Suppl. 48, 218s
Year: 2004

Zaphirlukast inhibits in vitro the respiratory burst of human neutrophils
Source: Eur Respir J 2001; 18: Suppl. 33, 79s
Year: 2001

The respiratory burst of human neutrophils is inhibited in vitro by Montelukast
Source: Eur Respir J 2002; 20: Suppl. 38, 620s
Year: 2002

The inducible kinin B1 receptor stimulates human airway fibroblast (Fb) proliferation
Source: Eur Respir J 2004; 24: Suppl. 48, 37s
Year: 2004

The cannabinoid receptor agonist, WIN 55,212-2, inhibits antigen-induced plasma extravasation in guinea pig airways
Source: Annual Congress 2010 - Models of airways disease
Year: 2010


Endothelin receptor B (ETBR) dependent GM-CSF mRNA stabilization explains the higher efficacy of bosentan vs. ambrisentan in the reduction of GM-CSF release from human airway smooth muscle cells (HASMCs)
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011

Endothelin receptor antagonists (ERAs) neutralize LPS-induced cytokine release from pulmonary vascular smooth muscle cells (PVSMCs) by down-regulation of CD14
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013

Liver-X-receptor agonists, but not dexamethasone, inhibit leukotriene production from human white blood cells pretreated with GM-CSF and activated with fMLP
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007


Protease-activated receptor 2 (PAR2) stimulation potentiates citric acid induced cough by sensitising the vanilloid receptor-1 (TRPV1)
Source: Annual Congress 2003 - Novel drugs under development for the treatment of respiratory diseases
Year: 2003


Modulation of transient receptor potential vanilloid-1 (TRPV1) by inhaled prostaglandin-E2 (PGE2) and bradykinin (BK) is associated with increased cough sensitivity to capsaicin (CPS) and autonomic dysregulation of cardiac rhythm in healthy subjects
Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease
Year: 2020


Suppression of basophil activation via histamine receptor 2 (HR2)
Source: Eur Respir J 2005; 26: Suppl. 49, 585s
Year: 2005